SEC 13F Intelligence

Consonance Capital Management LP / CMPX

Consonance Capital Management LP’s Compass Therapeutics Inc Position

Does Consonance Capital Management LP own Compass Therapeutics Inc (CMPX)? Not currently — the last reported position was 1.60M shares worth $4M in Q2 2022; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$4M
Q2 2022
Shares
1.60M
% of Portfolio
+17.79%
Quarters Held
3
position exited

Position History CMPX

Reported value by quarter
Q4 ’21: $11MQ4 ’21Q1 ’22: $5MQ1 ’22Q2 ’22: $4MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20221.60M$4M+17.79%
Q1 20223.50M$5M+8.05%
Q4 20213.50M$11M+7.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of CMPX.